Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Embed Code Disclaimer Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Latest articles Bitcoin lower than where it was before White House Crypto Summit Market Movers: The Opening Bell March 11, 2025 Financial services industry embracing AI for customer service & fraud detection Market Movers: The Opening Bell March 11, 2025 Gold looking to benefit from safe-haven demand as recession fears mount Market Movers: The Opening Bell March 11, 2025 Cross-border payment innovation accelerating across financial services Market Movers: The Opening Bell March 11, 2025 Related articles Bitcoin lower than where it was before White House Crypto Summit Market Movers: The Opening Bell March 11, 2025 Financial services industry embracing AI for customer service & fraud detection Market Movers: The Opening Bell March 11, 2025 Gold looking to benefit from safe-haven demand as recession fears mount Market Movers: The Opening Bell March 11, 2025